ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05879913

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
  • Indiana University Registry lists this organization as the lead sponsor
  • Pfizer Registry lists this organization as a collaborator
Registry
  • NCT NCT05879913
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05879913. Randomized; no masking; primary purpose diagnostic. Start 2023-12-15 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Condition
Prostate Cancer
Intervention (Device)
Coronary CT Angiography (CCTA)
Lead sponsor
Indiana University (class: other)
Collaborator
National Comprehensive Cancer Network (class: research network)
Collaborator
Pfizer (class: industry)
Collaborator
Sumitomo Pharma America, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05879913
Content hash
c0f21fb0b4f7ae67e44193083299234485d518daa09252149000df1ce09c5675